SEARCH

SEARCH BY CITATION

References

  • 1
    Andrade CA. peculiar form of peripheral polyneuropathy: Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408 27.
  • 2
    Andersson R. Familial amyloidosis with polyneuropathy: a clinical study based on patients living in northern Sweden. Acta Med Scand 1976; 198: 1 64.
  • 3
    Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116: 880 88.
  • 4
    Saraiva MJ, Costa PP, Birken S, Goodman DS. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 1983; 96: 261 70.
  • 5
    Coutinho P, Martins da Silva A, Kopes Lima J, Resende Barbosa A. Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In: GlennerG, PinhoE, CostaP & Folcao de FreitasA, eds. Amyloid and Amyloidosis. Amsterdam: Excerpta Medica, 1980; 88 98.
  • 6
    Suhr O, Danielsson Å, Steen L. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of patients with familial amyloidosis with polyneuropathy. Scand J Gastroenterol 1992; 27: 201 7.
  • 7
    Ando Y, Araki S, Ando M. Transthyretin related amyloidosis. Intern Med 1993; 32: 920 22.
  • 8
    Ando Y, Obayashi K, Tsuji A et al. Radiolabelled meta-iodobenzylguanidin in assessment of autonomic dysfunction. Lancet 1994; 343: 984 5.
  • 9
    Allescher H & Ahmed S. Postulated physiological and pathophysiological roles on motility. In: DanielE, ed. Neuropeptides Function in Gastrointestinal Tract. Boston: CRC Press, 1990; 309 400.
  • 10
    El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994; 35: 1413 18.
  • 11
    El-Salhy M & Suhr O. Endocrine cells in rectal biopsy specimens from patients with familial amyloidotic polyneuropathy. Scand J Gastroenterol 1996; 31: 68 73.
  • 12
    El-Salhy M, Stenling R, Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 1993; 28: 809 15.
  • 13
    El-Salhy M, Sandström O, Näsström E, Mustajbasic M, Zachrisson S. Application of computer image analysis in endocrine cell quantification. Histochem J 1997; 29: 249 56.
  • 14
    Sjölund K, Sandén G, Håkansson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983; 85: 1120 30.
  • 15
    Holmgren G, Ando Y, Wikström L, Rydh A, Suhr O. Discordant symptoms in monozygotic twins with familial amyloidotic polyneuropathy (FAP) (TTR met 30). Amyloid Int J Exp Clin Invest 1997; 4: 178 80.
  • 16
    Mannon P & Taylor IL. The pancreatic polypeptide family. In: WalshJH, DockaryGJ, eds. Gut Peptides: Biochemistry and Physiology. New York: Raven Press, 1994; 341 70.
  • 17
    Goarard DA, Libby GW, Farthing MJ. 5-Hydroxytryptamine and human intestinal motility: effect of inhibiting 5-hydroxytryptamine uptake. Gut 1994; 35: 496 500.
  • 18
    Chiba T & Yamada T. Gut somatostatin. In: WalshJH, DockaryGJ, eds. Biochemistry and Physiology. New York: Raven Press, 1994; 123 45.